Compare PCRX & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | LEGH |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | N/A | 592 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 489.1M |
| IPO Year | 2010 | 2018 |
| Metric | PCRX | LEGH |
|---|---|---|
| Price | $22.70 | $20.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $37.20 | $25.00 |
| AVG Volume (30 Days) | ★ 604.7K | 128.4K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | N/A |
| EPS | 0.16 | ★ 1.74 |
| Revenue | ★ $541,533,000.00 | $164,567,000.00 |
| Revenue This Year | $7.10 | $10.71 |
| Revenue Next Year | $9.15 | N/A |
| P/E Ratio | $142.31 | ★ $11.80 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $18.29 |
| 52 Week High | $27.99 | $29.45 |
| Indicator | PCRX | LEGH |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 55.03 |
| Support Level | $22.57 | $20.56 |
| Resistance Level | $23.94 | $20.77 |
| Average True Range (ATR) | 0.90 | 0.79 |
| MACD | -0.02 | 0.18 |
| Stochastic Oscillator | 53.40 | 84.28 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.